StocksMedium•5 November 2026•
1 min read
LB Pharmaceuticals Reports $59.1 Million Net Loss in Q3 2026 Results
Key Facts
1LB Pharmaceuticals reported a net loss of $59.1 million for the third quarter ended September 30, 2026.
2The company's cash position stood at $403.8 million as of the end of the third quarter.
LB Pharmaceuticals reported a net loss of $59.1 million for the third quarter ended September 30, 2026. Benzinga reported that the company's cash position stood at $403.8 million as of the end of the third quarter.
LBRX closed at $40.85 on November 4, 2026, with the stock trading between a low of $38.75 and a high of $42 during that session. These financial results follow the company's reported cash balance of $403.8 million as of September 30, 2026.